Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Terlipressin for Injection

Approval Number

国药准字HJ20140690

CompanyFerring GmbH

Registration Date

April 25, 2024

Previous Approval Numbers

H20140690

Drug Information

Generic Name

注射用特利加压素

Trade Name

可利新

Dosage Form

注射剂

Strength

1mg

Drug Type

化学药品

Registration Date

April 25, 2024

Expiry Date

April 24, 2029

Company Information

Applicant Company

Company NameFerring GmbH

Company Address

Wittland 11, D-24109 Kiel, Germany

Manufacturing Company

Company NameFerring GmbH

Company Address

Wittland 11, D-24109 Kiel, Germany

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy